Skip to main content
Log in

Treating Recurrent Affective Disorders During and After Pregnancy

What Can Be Taken Safely?

Drug Safety Aims and scope Submit manuscript

Summary

Since pregnancy and the time thereafter is a precarious period for women with recurrent affective disorders and their offspring, it is important to determine the risk of various treatments for such disorders. This review assesses the risk to the fetus, the perinatal risks for mother and infant, the risks associated with treatment during the puerperium and breastfeeding, and the risks to the later development of the child.

This review considers treatment with lithium, tricyclic antidepressants (TCAs), selective serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitors (SSRIs), monoamine oxidase inhibitors, other antidepressants, and the anticonvulsants carbamazepine and valproic acid (sodium Valproate).

According to available evidence, use of lithium, TCAs and SSRIs is justified during and after pregnancy if treatment is required; no prophylactic treatment has a lower risk: benefit ratio. The review provides guidelines for the use of these drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cade JFJ. Lithium salts in the treatment of psychotic excitement. Med J Aust 1949; 36: 349–52

    Google Scholar 

  2. Schou M, Juel-Nielsen N, Strömgren E, et al. The treatment of manic psychoses by the administration of lithium salts. J Neurol Neurosurg Psychiatry 1954; 17: 250–60

    Article  PubMed  CAS  Google Scholar 

  3. Baastrup PC, Schou M. Lithium as a prophylactic agent: its effect against recurrent depressions and manic-depressive psychosis. Arch Gen Psychiatry 1967; 16: 162–72

    Article  PubMed  CAS  Google Scholar 

  4. Baastrup PC, Poulsen JC, Schou M, et al. Prophylactic lithium: double-blind discontinuation in manic-depressive and recurrent-depressive disorders. Lancet 1970; II: 326–30

    Article  Google Scholar 

  5. Schou M. The ’scandinavian Register of Lithium Babies’. Acta Psychiatr Scand 1969; 207 Suppl.: 97

    Google Scholar 

  6. Schou M, Goldfield MD, Weinstein MR, et al. Lithium and pregnancy. I, Report form the Register of Lithium Babies. BMJ 1973; 2: 135–6

    Article  PubMed  CAS  Google Scholar 

  7. Weinstein MR, Goldfield MD. Pharmacology: lithium teratology. In: Gershon S, Shopsin B, editors. Lithium: its role in psychiatric research and treatment. New York: Plenum, 1973: 147–66

    Google Scholar 

  8. Schou M. Lithium treatment during pregnancy, delivery, and lactation: an update. J Clin Psychiatry 1990; 51: 410–3

    PubMed  CAS  Google Scholar 

  9. Källen B, Tandberg A. Lithium and pregnancy: a cohort study on manic-depressive women. Acta Psychiatr Scand 1983; 68: 134–9

    Article  PubMed  Google Scholar 

  10. Cunniff CM, Sahn DJ, Reed KL, et al. Pregnancy outcome in women treated with lithium [abstract]. Teratology 1989; 39:447

    Google Scholar 

  11. Jacobson SJ, Jones K, Johnson K, et al. Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester. Lancet 1992; 339: 530–3

    Article  PubMed  CAS  Google Scholar 

  12. Cohen LS, Friedman JM, Jefferson JW, et al. A reevaluation of risk of in utero exposure to lithium. JAMA 1994; 271: 146–50

    Article  PubMed  CAS  Google Scholar 

  13. Zalzstein E, Koren G, Einarson T, et al. A case-control study on the association between first trimester exposure to lithium and Ebstein’s anomaly. Am J Cardiol 1990; 65: 817–8

    Article  PubMed  CAS  Google Scholar 

  14. Edmonds LD, Oakley GP. Ebstein’s anomaly and maternal lithium exposure during pregnancy. Teratology 1990; 41: 551–2

    Google Scholar 

  15. Sipek A. Lithium and Ebstein’s anomaly. Cor Vasa 1989; 31: 149–56

    PubMed  CAS  Google Scholar 

  16. Källen SJB. Lithium therapy and congenital malformations. In: Schrauzer GN, Klippel KF, editors. Lithium in biology and medicine: new applications and developments. Weinheim: New York, 1991: 121–30

    Google Scholar 

  17. Thomsen K, Schou M. Renal lithium excretion in man. Am J Physiol 1968; 215: 823–7

    PubMed  CAS  Google Scholar 

  18. Schou M, Amdisen A, Steenstrup OR. Lithium and pregnancy. II: hazards to women given lithium during pregnancy and delivery. BMJ 1973; 2: 137–8

    Article  PubMed  CAS  Google Scholar 

  19. Wilbanks GD, Bressler B, Peete CH, et al. Toxic effects of lithium carbonate in a mother and newborn infant. JAMA 1970; 213: 865–7

    Article  PubMed  CAS  Google Scholar 

  20. Vacaflor L, Lehmann HE, Ban TA. Side effects and teratogenicity of lithium carbonate treatment. J Clin Pharmacol 1970; 10: 387–9

    CAS  Google Scholar 

  21. Nishiwaki T, Tanaka K, Sekiya S. Acute lithium intoxication in pregnancy. Int J Gynecol Obstet 1996; 52: 191–2

    Article  CAS  Google Scholar 

  22. Tunnesen WW, Hertz CG. Toxic effects of lithium in newborn infants: a commentary. J Pediatrics 1972; 81: 804–7

    Article  Google Scholar 

  23. Stothers K, Wilson DW, Royston N. Lithium toxicity in the newborn. BMJ 1973; 3: 233–4

    Article  PubMed  CAS  Google Scholar 

  24. Stevens D, Burman D, Midwinter A. Transplacental lithium poisoning. Lancet 1974; II: 595

    Article  Google Scholar 

  25. Nars P, Girard J. Lithium carbonate intake during pregnancy leading to large goiter in a premature infant. Am J Dis Child 1977; 131: 924–5

    PubMed  CAS  Google Scholar 

  26. Mizrahi EM, Hobbs JF, Goldsmith DI. Nephrogenic diabetes insipidus in transplacental lithium intoxication. J Pediatrics 1979; 94: 493–5

    Article  CAS  Google Scholar 

  27. Arnon RG, Marin-Garcia J, Peeden JN. Tricuspid valve regurgitation and lithium carbonate toxicity in a newborn infant. Am J Dis Childhood 1981; 135: 941–3

    CAS  Google Scholar 

  28. Filtenborg JA. Persistent pulmonary hypertension after lithium intoxication in the newborn. Eur J Pediatr 1982; 138: 321–3

    Article  PubMed  CAS  Google Scholar 

  29. Morrell P, Sutherland GR, Buamah PK, et al. Lithium toxicity in a neonate. Arch Dis Child 1983; 58: 539–41

    Article  PubMed  CAS  Google Scholar 

  30. Wilson N, Forfar JC, Godman MJ. Atrial flutter in the newborn resulting from maternal lithium ingestion. Arch Dis Child 1983; 58: 538–49

    Article  PubMed  CAS  Google Scholar 

  31. Krause S, Ebbesen F, Lange AP. Polyhydramnios with maternal lithium treatment. Obstet Gynecol 1990; 75: 504–6

    PubMed  CAS  Google Scholar 

  32. Ang MS, Thorp JA, Parisi VM. Maternal lithium therapy and polyhydramnios. Obstet Gynecol 1990; 76: 517–9

    PubMed  CAS  Google Scholar 

  33. Kastrup M, Lier L, Rafaelsen OJ. Psychiatric illness in relation to pregnancy and childbirth. I. Methodological considerations. Nord Psykiatr Tidsskr 1989; 43: 531–4

    Article  Google Scholar 

  34. Lier L, Kastrup M, Rafaelsen OJ. Psychiatric illness in relation to pregnancy and childbirth. II. Diagnostic profiles, psychosocial and perinatal aspects. Nord Psykiatr Tidsskr 1989; 43: 535–42

    Article  Google Scholar 

  35. Austin MV. Puerperal affective psychosis: is there a case for lithium prophylaxis? Br J Psychiatry 1992; 161: 692–4

    Article  PubMed  CAS  Google Scholar 

  36. Cohen LS, Sichel DA, Robertson LM, et al. Postpartum prophylaxis for women with bipolar disorder. Am J Psychiatry 1995; 152: 1641–5

    PubMed  CAS  Google Scholar 

  37. Schou M, Amdisen A. Lithium and pregnancy. III: lithium ingestion by children breast-fed by women on lithium treatment. BMJ 1973; 2: 138

    Article  PubMed  CAS  Google Scholar 

  38. Schou M. Lithium treatment of manic-depressive illness: a practical guide. 4th rev ed. Basel: Karger, 1989

    Google Scholar 

  39. Skausig OB, Schou M. Diegivning under lithiumbehandling. Ugeskr Læg 1977; 139: 400–1

    PubMed  CAS  Google Scholar 

  40. Wisner KL, Perel JM, Findling RL. Antidepressant treatment during breast-feeding. Am J Psychiatry 1996; 153: 1132–7

    PubMed  CAS  Google Scholar 

  41. Schou M. Lithium treatment of manic-depressive illness: a practical guide. 5th rev ed. Basel: Karger, 1993

    Google Scholar 

  42. Schou M. What happened later to the lithium babies? A follow-up study of children born without malformations. Acta Psychiatr Scand 1976; 54: 193–7

    Article  PubMed  CAS  Google Scholar 

  43. Wehr TA, Goodwin FK. Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry 1979; 36: 555–9

    Article  PubMed  CAS  Google Scholar 

  44. Akiskal HS, Mallya G. Criteria for the ’soft’ bipolar spectrum: treatment implications. Psychopharmacol Bull 1987; 23: 68–73

    PubMed  CAS  Google Scholar 

  45. Altschuler LL, Cohen L, Szuba MP, et al. Pharmacological management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry 1996; 153: 592–606

    Google Scholar 

  46. Pastuszak A, Schick-Boschetto B, Zuber C, et al. Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA 1993; 269: 2246–8

    Article  PubMed  CAS  Google Scholar 

  47. McElhatton PR, Garbis HM, Elefant E, et al. The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. Reprod Toxicol 1996; 10: 285–94

    Article  PubMed  CAS  Google Scholar 

  48. Chambers CD, Johnson KA, Dick LM, et al. Birth outcome in pregnant women taking fluoxetine. N Engl J Med 1996; 335: 1010–5

    Article  PubMed  CAS  Google Scholar 

  49. Robert E. Treating depression in pregnancy. N Engl J Med 1996; 335: 1056–8

    Article  PubMed  CAS  Google Scholar 

  50. Cohen LS, Rosenbaum JF. Birth outcome in pregnant women taking fluoxetine [letter]. N Engl J Med 1997; 336: 872

    Article  PubMed  CAS  Google Scholar 

  51. Goldstein DJ, Sundell KL, Corbin LA. Birth outcomes in pregnant women taking fluoxetine [letter]. N Engl J Med 1997; 336: 872–3

    Article  PubMed  CAS  Google Scholar 

  52. Jones KL, Johnson KA, Chambers CD. Birth outcomes in pregnant women taking fluoxetine [letter]. N Engl J Med 1997; 336: 873

    Article  PubMed  Google Scholar 

  53. Webster PAC. Withdrawal symptoms in neonates associated with maternal antidepressants therapy [letter]. Lancet 1973; II: 3189

    Google Scholar 

  54. Eggermont E. Withdrawal symptoms in neonates associated with maternal imipramine therapy [letter]. Lancet 1973; II: 680

    Article  Google Scholar 

  55. Cowe L, Lloyd DJ, Dawling S. Neonatal convulsions caused by withdrawal from maternal clomipramine. BMJ 1982; 284: 1837–8

    Article  PubMed  CAS  Google Scholar 

  56. Spencer MJ. Fluoxetine hydrochloride (Prozac) toxicity in the neonate. Pediatrics 1993; 92: 721–2

    PubMed  CAS  Google Scholar 

  57. Baum AL, Misri S. Selective serotonin-reuptake inhibitors in pregnancy and lactation. Harvard Rev Psychiatry 1996; 4: 117–25

    Article  CAS  Google Scholar 

  58. Lidén K, Eilström KG. Obervandum om antidepressiva under graviditet: Även låga doser kan påverka barnet. Läkartidn 1997; 94: 2086–91

    Google Scholar 

  59. Wisner KL, Wheeler SB. Prevention of recurrent Postpartum major depression. Hosp Commun Psychiatry 1994; 45: 1191–6

    CAS  Google Scholar 

  60. Altschuler LL, Burt VK, McMullen M, et al. Breastfeeding and sertraline: a 24-hour analysis. J Clin Psychiatry 1995; 56: 243–5

    Google Scholar 

  61. Taddio A, Ito S, Koren G. Excretion of fluoxetine and its metabolite, norfluoxetine, in human breast milk. J Clin Pharmacol 1996; 36: 42–7

    PubMed  CAS  Google Scholar 

  62. Wisner KL, Perel JM, Findling RL. Antidepressant treatment during breast-feeding. Am J Psychiatry 1996; 153: 1132–7

    PubMed  CAS  Google Scholar 

  63. Yoshida K, Smith B, Craggs M, et al. Investigation of pharmacokinetics and of possible adverse effects in infants exposed to tricyclic antidepressants in breast-milk. J Affect Disord 1997; 43: 225–37

    Article  PubMed  CAS  Google Scholar 

  64. Mammen OK, Perel JM, Rudolph G, et al. Sertraline and norsertraline levels in three breastfed infants. J Clin Psychiatry 1997; 58: 100–3

    Article  PubMed  CAS  Google Scholar 

  65. Jensen PN, Olesen OV, Bertelsen A, et al. Citalopram and desmethylcitalopram in breast milk and in serum of mother and infant. Ther Drug Monit 1997; 18: 236–9

    Article  Google Scholar 

  66. Nulman I, Rovet J, Stewart DE, et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997: 336: 258–62

    Article  PubMed  CAS  Google Scholar 

  67. Jones KL, Lacro RV, Johnson KA, et al. Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 1989: 320: 1661–6

    Article  PubMed  CAS  Google Scholar 

  68. Rosa FW. Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med 1991; 324: 674–7

    Article  PubMed  CAS  Google Scholar 

  69. Ornoy A, Cohen E. Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy. Arch Dis Child 1996; 75: 517–20

    Article  PubMed  CAS  Google Scholar 

  70. Robert E, Guibaud P. Maternal valproic acid and congenital neural tube defects [letter]. Lancet 1982; II: 937

    Article  Google Scholar 

  71. Bjerkedal T, Czeizel A, Goujard J, et al. Valproic acid and spina bifida [letter]. Lancet 1982; II: 1096

    Article  Google Scholar 

  72. Lindhout D, Meinardi H. Spina bifida and in-utero exposure to valproic acid. Lancet 1984; II: 396

    Article  Google Scholar 

  73. DiLiberti JH, Farndon PA, Dennis NR, et al. The fetal Valproate syndrome. Am Med J Genet 1984; 19: 473–81

    Article  CAS  Google Scholar 

  74. Ardinger HH, Atkin JF, Blackston D, et al. Verification of the fetal Valproate syndrome phenotype. Am J Med Genet 1988; 29: 171–85

    Article  PubMed  CAS  Google Scholar 

  75. Thisted E, Ebbesen F. Malformations, withdrawal manifestations, and hypoglycaemia after exposure to Valproate in utero. Arch Dis Child 1993; 69: 288–91

    Article  PubMed  CAS  Google Scholar 

  76. Battino D, Binelli S, Caccamo ML, et al. Malformations in off-spring of 305 epileptic women: a prospective study. Acta Neurol Scand 1992; 85: 204–7

    Article  PubMed  CAS  Google Scholar 

  77. Niebyl JR, Blake DA, Freeman JM, et al. Carbamazepine levels in pregnancy and lactation. Obstet Gynecol 1979; 53: 139–40

    PubMed  CAS  Google Scholar 

  78. Abrams R. Electroconvulsive therapy. 2nd ed. New York: Oxford University Press, 1992: 103–4

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mogens Schou.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schou, M. Treating Recurrent Affective Disorders During and After Pregnancy. Drug-Safety 18, 143–152 (1998). https://doi.org/10.2165/00002018-199818020-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199818020-00006

Keywords

Navigation